Schwartz Biomedical

Orthopedic Medical Devicesschwartzbiomedical.com

Schwartz Biomedical (dba BioPoly) is a Fort Wayne, Indiana orthopedic medical device company developing self-lubricating synthetic cartilage implants that serve orthopedic surgeons and patients with joint cartilage defects in the toe, elbow, and knee.

Company typePrivate
Founded2004
HeadquartersFort Wayne, United States
Headcount1–10
GTM typeB2B
OfferingHardware or Manufacturing

What Schwartz Biomedical does

Schwartz Biomedical, operating commercially as BioPoly LLC, is a Fort Wayne, Indiana-based orthopedic medical device company founded in 2004 that develops and manufactures implants made from a proprietary self-lubricating biomaterial combining Hyaluronic Acid (HA) and Ultrahigh Molecular Weight Polyethylene (UHMWPE). The resulting material is designed to mimic the function of natural cartilage, providing a targeted, minimally invasive option for joint repair in indications where existing biological treatments are insufficient and total joint replacement is premature. Its commercial product portfolio comprises the BioPoly Great & Lesser Toe Implants for toe cartilage repair, the BioPoly Radial Head Implant for elbow joint restoration, and a Products Pipeline representing future innovations; a BioPoly Knee Implant is in active FDA-approved clinical trial enrollment (NCT06915363) and remains limited to investigational use in the United States.

BioPoly operates a B2B2C go-to-market model, selling implants to hospitals and surgical centers through orthopedic surgeons, while maintaining a patient-facing website channel ('For Patients') that connects prospective patients with surgeons who use its products. Revenue is generated from hardware sales of these orthopedic implants, with quote-based pricing through medical device procurement channels rather than publicly disclosed pricing. The company is privately held, employs 1-10 people, and operates exclusively within the United States, with no disclosed external investors, funding rounds, or ownership structure beyond its LLC designation in Indiana. Marketing is conducted through a multi-channel digital presence (Facebook, Instagram, LinkedIn, X), clinical study and case report publications, and patient testimonials, all aimed at both healthcare professionals and end patients.

Schwartz Biomedical firmographics

Firmographics

Name: Schwartz Biomedical
Legal name: BioPoly LLC
Website: https://schwartzbiomedical.com
Company type: Private
Founded year: 2004
Operating status: Operating
Headcount range: 1–10 employees
Short description: Schwartz Biomedical (dba BioPoly) is a Fort Wayne, Indiana orthopedic medical device company developing self-lubricating synthetic cartilage implants that serve orthopedic surgeons and patients with joint cartilage defects in the toe, elbow, and knee.
Ownership category
akta.pro rank

Schwartz Biomedical industry classification

Industry

Product category: Orthopedic Medical Devices
NAICS: Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC: Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry: Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries: Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF)

Keywords

Orthopedic implants
Cartilage repair
Biomaterial medical devices
Joint resurfacing implants
Synthetic cartilage

Where Schwartz Biomedical is headquartered

Location

Headquarters

HQ city: Fort Wayne
HQ country: United States
HQ region: North America

Offices1 record

Markets served

Schwartz Biomedical business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

Orthopedic Implant Sales: BioPoly generates revenue through the sale of proprietary orthopedic implants (Great & Lesser Toe, Radial Head, Knee implants) made from their patented self-lubricating biomaterial. These are medical device implants sold to healthcare facilities and surgeons for patient procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Schwartz Biomedical product offering

Product offering

Core offering

Schwartz Biomedical, operating as BioPoly, develops and manufactures orthopedic implants made from a proprietary self-lubricating biomaterial that combines Hyaluronic Acid (HA) and Ultrahigh Molecular Weight Polyethylene (UHMWPE). The company's product line targets cartilage repair in the great/lesser toe, radial head (elbow), and knee joints, offering a minimally invasive alternative positioned between biological treatments and total joint replacement. The Knee implant is currently limited to investigational use in the United States under an FDA-approved clinical study.

Product overview

BioPoly develops and manufactures a portfolio of orthopedic implants made from a proprietary self-lubricating biomaterial combining hyaluronic acid (HA) and ultrahigh molecular weight polyethylene (UHMWPE). The product line includes four distinct implants: Great & Lesser Toe Implants for toe cartilage repair, Radial Head Implant for elbow joint restoration, Knee Implant for early-stage knee cartilage defect treatment, and a Products Pipeline for future innovations. These implants serve as minimally invasive alternatives to biological treatments and total joint replacements, designed to restore joint function and enable pain-free movement.

Differentiator

Problem solved

Functional benefit

Brands

BioPoly: Proprietary biomaterial combining hyaluronic acid and ultrahigh molecular weight polyethylene for synthetic cartilage implants.

Products and services

BioPoly Great & Lesser Toe Implants Orthopedic implants designed to relieve pain and restore toe function by replacing damaged cartilage in the great and lesser toes. Used by orthopedic surgeons for patients with toe joint cartilage defects.
BioPoly Radial Head Implant Elbow implant that restores anatomy and biomechanics using a durable synthetic cartilage material for radial head replacement. Used by orthopedic surgeons for patients requiring elbow joint restoration.
BioPoly Knee Implant Early intervention implant designed to replace painful knee cartilage defects, enabling faster recovery and improved mobility. Limited to investigational use in the United States under FDA clinical study.

Companies that use Schwartz Biomedical

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Schwartz Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Schwartz Biomedical partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Schwartz Biomedical competitors and assessment

Company assessment

Broad incumbents

Arthrex: Global leader in sports medicine and soft-tissue/cartilage repair implants and instruments, a broad incumbent covering BioPoly's clinical use cases.
Zimmer Biomet: Leading joint reconstruction and extremities implant maker whose portfolio overlaps BioPoly's knee, elbow and toe implant categories.
Stryker: One of the largest orthopedic implant manufacturers spanning knee, extremities and joint reconstruction, an incumbent in BioPoly's target segments.
Smith & Nephew: Major orthopedics player in joint reconstruction and sports medicine, offering competing cartilage and joint-repair solutions at scale.

Emerging players

Moximed: Focuses on implantable joint-preservation devices (knee) as alternatives to replacement, overlapping BioPoly's early-intervention thesis.

Direct peers

Episurf Medical: Provides individualized metal implants for focal cartilage/bone defects in the knee, directly competing in early-intervention joint resurfacing.
Active Implants: Develops the NUsurface synthetic meniscus implant for joint preservation, closely comparable as a synthetic-material, minimally invasive alternative to joint replacement.
CartiHeal (Smith+Nephew): Developer of the Agili-C cartilage repair implant for joint surface defects, targeting the same gap between biologics and joint replacement.
Vericel: Maker of MACI autologous cartilage repair product; competes for the same early-stage cartilage-defect patients BioPoly targets as an alternative to biologics.
Anika Therapeutics: Hyaluronic-acid-based orthopedic and regenerative company focused on joint preservation and cartilage/soft-tissue repair, directly overlapping BioPoly's HA-based cartilage-repair positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Schwartz Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Schwartz Biomedical leadership team

Management profile

Number of profiles

Profiles1 record

Schwartz Biomedical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Schwartz Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Schwartz Biomedical

What does Schwartz Biomedical do?

Is Schwartz Biomedical a public or private company?

Schwartz Biomedical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Schwartz Biomedical founded?

Schwartz Biomedical was founded in 2004. It employs 1 to 10 people.

Where is Schwartz Biomedical based?

Schwartz Biomedical is headquartered in Fort Wayne, United States, in the North America region.

How does Schwartz Biomedical make money?

One revenue line is on record: orthopedic Implant Sales.

Who are Schwartz Biomedical's main competitors?

Broad incumbents on record are Arthrex, Zimmer Biomet, Stryker and Smith & Nephew. Moximed is listed as an emerging player. Direct peers are Episurf Medical, Active Implants, CartiHeal (Smith+Nephew), Vericel and Anika Therapeutics.

Does Schwartz Biomedical have an API?

No public API is recorded for Schwartz Biomedical.

What industry is Schwartz Biomedical in?

Schwartz Biomedical's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.